PD-L1 blockade enhances anti-tumor efficacy of NK cells.
Oncoimmunology. 2018 Aug 27;7(11):e1509819. doi: 10.1080/2162402X.2018.1509819. eCollection 2018.
Oncoimmunology. 2018.
PMID: 30377572
Free PMC article.